LY310762 HCl is a potent and selective antagonist of the 5-HT2A serotonin receptor. It is primarily utilized in research settings to study its effects on serotonin-mediated biological pathways, particularly in modulating 5-HT2A receptor activity. It is often employed in preclinical studies to investigate its potential role in conditions such as migraine, schizophrenia, and other psychiatric disorders where 5-HT2A dysregulation is implicated. Researchers use it to explore its efficacy in experimental models, aiming to understand its therapeutic potential. Its application is largely confined to laboratory studies, contributing to the development of novel pharmacological strategies.